Extracellular release of the ‘differentiation enhancing factor’, a HMG1 protein type, is an early step in murine erythroleukemia cell differentiation  by Melloni, E. et al.
FEBS Letters 368 (1995) 466-470 FEBS 15788 
Extracellular release of the 'differentiation enhancing factor', a HMG1 
protein type, is an early step in murine erythroleukemia cell differentiation 
E. Melloni*, B. Sparatore, M. Patrone, A. Pessino, M. Passalacqua, S. Pontremoli 
Institute of Biochemistry, Viale Benedetto XV, 1-16132 Genova, Italy 
Received 19 May 1995; revised version received 13 June 1995 
Abstract Differentiation enhancing factor (DEF) is a 29 kDa 
protein expressed in murine erythrolenkemia (MEL) cells and 
active in promoting a significant increase in the rate of hexameth- 
ylenebisacetamide induced differentiation of these cells. The fac- 
tor was recently shown to possess an amino acid sequence identi- 
cal to that reported for one of the HMG1 proteins, designated 
as 'amphoterin' on the basis of its highly dipolar sequence. In the 
present study, we have expressed DEF cDNA in an E. coli strain 
and found that the recombinant protein has functional properties 
identical to those observed with native DEF. Furthermore, we 
demonstrate that, following MEL cell stimulation with the chem- 
ical inducer, DEF is secreted in large amounts in the extracellular 
medium. In fact, the N-terminal sequence and the partial amino 
acid sequence of tryptic peptides from the secreted protein corre- 
spond to those of DEF isolated from the soluble fraction of resting 
MEL cells. These results are indicative for an extracellular local- 
ization as the site of action of DEF and suggest a novel function 
for proteins belonging to the HMG1 family. Finally, the early 
decay of DEF mRNA, in chemical induced MEL cells, support 
the hypothesis that the involvement of the enhancing factor occurs 
and is completed in the early phases of cell differentiation. 
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protein factor possesses an amino acid sequence identical to 
that reported for a heparin binding protein isolated from devel- 
oping rat brain [9]. Due to its highly dipolar sequence, charac- 
teristic of the family of HMG1 polypeptides, this protein has 
been designated as 'amphoterin' [10]. The identity between 
MEL cell DEF and 'amphoterin' was confirmed by analysis of 
the sequence of the cDNA encoding DEF protein [10]. In order 
to provide additional data that could unequivocally attribute 
the differentiation enhancing activity to the protein factor iso- 
lated from MEL cells, we have expressed DEF in E. coli cells 
and evaluated the biological activity of the recombinant pro- 
tein. In addition, we have isolated and characterized the protein 
carrying DEF activity present in the extracellular medium of 
MEL cells following stimulation with HMBA. The results ob- 
tained indicated that both recombinant DEF and native DEF 
purified from the extracellular medium expressed a biological 
activity corresponding to that of the protein factor present in 
the soluble fraction of resting MEL cells. Evidence for the 
identity in molecular structure between the secreted and the 
intracellular DEF protein is also provided. Taken together the 
present and previous results [9] strongly indicate a novel func- 
tion of proteins belonging to the HMG1 family [11]. 
2. Materials and methods 
1. Introduction 
MEL cells are induced to terminal erythroid differentiation 
by hexamethylenebisacetamide (HMBA) through a multistep 
process [1,2], which involves also down-regulation of specific 
protein kinase C (PKC) isoforms shown to be functionally 
related to the differentiation process [3-6]. The rate of appear- 
ance of differentiated cells has previously been shown to un- 
dergo a significant acceleration following addition to the cell 
culture medium of a protein factor named 'differentiation en- 
hancing factor' (DEF), which is synthesized in resting cells and 
retained in the intracellular compartment [7]. Altogether, these 
observations suggested an extracellular function for DEF, and 
that this localization could be achieved only through a secre- 
tory process, indicating DEF secretion as one of the earlier 
events in cell differentiation. Moreover, the powerful in vitro 
activating effect of DEF on ~-PKC isotype was considered of 
potential interest for the understanding of the biological activ- 
ity of the factor [8]. Recently, it has been demonstrated that this 
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2.1. Cell culture and differentiation 
MEL cell clones N23 and C44 were cultured in c~-MEM supple- 
mented with 10% fetal calf serum, as previously described [12,13]. N23 
cell clone was used for the assay of DEF activity, due to its low rate 
of differentiation. C44 cell clone was utilized as the source of intracel- 
lular and extracellular DEF. N23 MEL cells (10 s cellslml) were induced 
to differentiate by addition of 5 mM hexamethylenebisacetamidc 
(HMBA) and, at the indicated times the amount of differentiated cells 
was evaluated by staining with benzidine [14]. 
2.2. Purification of DEF from MEL cell soluble fraction 
C44 MEL cells were collected, washed and lysed as previously re- 
ported [9]. The cell soluble fraction was prepared and the protein factor 
isolated following the purification procedure previously described [9]. 
2.3. Purification of DEF from MEL cell extracellular medium 
44 MEL cells (2 x 10 l° cells) were collected and washed as above and 
resuspended in 500 ml of serum-free culture medium containing 5 mM 
HMBA. After 4 h of incubation at 37°C, the cell suspension was 
centrifuged at800 x g for 10 rain; thereafter the cells and the extracellu- 
lar medium were separately collected and processed as follows: cells 
were washed and lysed as reported above and the cell soluble fraction 
was submitted to chromatography on heparin-immobilized column as 
previously described [9]; the extracellular medium was concentrated by
ultrafiltration to 10 ml, heated at 85°C for 3 min and the precipitated 
material discarded by centrifugation. The clear supernatant was diluted 
to 50 ml with 50 mM sodium phosphate buffer, pH 6.8, containing 
1 mM EDTA, 100 /2M leupeptin and 2 mM phenylmethylsulfo- 
nilfluoride and the DEF protein purified following all the chromato- 
graphic steps described above for the purification of DEF from the cell 
soluble fraction. 
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2.4. Assay of DEF activity 
N23 MEL cells (105 ceUs/ml) were incubated in standard culture 
conditions with 5 mM HMBA in the absence or presence of DEF 
samples. After 72 h the amount of differentiated cells was evaluated by 
staining with benzidine [14]. One unit of DEF activity is defined as the 
amount which doubles the proportion of benzidine reactive cells in the 
specified assay conditions. 
2.5. Expression f DEF as fusion protein i  E. coli 
Total RNA was isolated from C44 MEL cells by extraction with 
guanidium thiocyanate [15], and 5 pg were reversed transcribed by 
using oligo(dT)ls as a primer. The oligonucleotides primers for the 
amplification reaction and the polymerase chain reaction conditions 
have been previously described [9]. The insert was ligated into 
EcoRI/BamHI cut pGEX2T expression vector (Pharmacia LKB Bio- 
technology) and E. coli TOP 10 F' cells were transformed using electro- 
poration (BioRad Gene Pulser). Recombinant plasmids, were then se- 
quenced by the dideoxynucleotide chain termination method [16]. As 
a control, bacterial cells were transformed by using intact pGEX2T 
vector and used to express glutathione S-transferase (GST). Expression 
and purification of GST and GST-DEF were carried out as indicated 
by the manufacturer. Where indicated, GST-DEF was cleaved with 
thrombin [17] followed by isolation of recombinant DEF protein by 
affinity chromatography onheparin-immobilized column [9]. 
2.6. Electrophoretic methods 
SDS-PAGE was carried out according to Laemmli [18]. For North- 
ern blotting 20 pg of total RNA from C44 MEL cells were submitted 
to electrophoresis on 1.2% agarose gel [15] and transferred to a nylon 
filter (Hybond-N +, Amersham Int.). cDNA clones, from nucleotide 75 
to 734 of mouse HMG1 protein [19] and from nucleotide 217 to 540 
of mouse fl-actin cDNA [20], were labelled using [32p]dCTP (Rediprime 
kit, Amersham Int.) and used to probe the filter. The radioactive bands 
were excised from the filter and counted in a scintillation fl-counter. 
3. Results 
3.1. Expression of DEF protein 
Starting from MEL cell total RNA, DEF cDNA was pre- 
pared and used to express DEF in bacterial cells as a fusion 
protein with the Schistosoma j ponicum GST. The fusion pro- 
tein was then purified by affinity chromatography (see section 
2). The addition of increasing amounts of fusion protein to the 
culture medium of N23 MEL cells, together with the inducer 
HMBA, promoted a dose-dependent acceleration i the rate of 
accumulation of differentiated cells, indicating that the protein 
sinthesized by bacterial cells displayed a differentiation enhanc- 
ing activity identical to that shown by native DEF protein 
obtained from MEL cell soluble fraction (Fig. 1). The maximal 
stimulatory effect was obtained at fusion protein concentra- 
tions of approximately 40-50 pM, indicating a specific activity 
of this protein approximately two-fold lower as compared to 
pure native DEF. 
In order to obtain the 29 kDa protein fragment, the fusion 
protein was cleaved by digestion with thrombin. The efficiency 
in the stimulation of MEL cell differentiation was not only 
tested for the cleaved 29 kDa protein but also for GST ex- 
pressed by the same bacterial cells, as an internal control. The 
29 kDa protein fragment was maximally effective at concentra- 
tions of 20-30 pM, almost identical to those observed with 
native DEF (Fig. 1). GST revealed no significant effect even at 
the highest concentrations utilized. 
3.2. Isolation of DEF from MEL cell culture medium 
Previous results indicated that DEF had to be secreted into 
the extracellular compartment in order to express its biological 
activity. This observation emerged from data indicating that 
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Fig. 1. Efficiency of native and recombinant DEF on MEL cell differ- 
entiation. N23 MEL cell differentiation was induced as reported in 
section 2in the absence or presence of the indicated amounts of recom- 
binant or native DEF, or GST as follows: (o), DEF from MEL cell 
soluble fraction; (*), recombinant DEF isolated after digestion of the 
fusion protein with thrombin; (~,), recombinant GST-DEF fusion pro- 
tein; (©), recombinant GST. After 72 h of culture the proportion of 
benzidine reactive cells was determined as described in section 2. 
the protein, although present in the soluble fraction of unin- 
duced cells, expressed its differentiation enhancing activity 
when added to MEL cell culture medium. Thus it was reason- 
able to postulate that the protein was released from the intracel- 
lular compartment during stimulation with the chemical in- 
ducer. To test directly this hypothesis, cells were suspended in 
fresh serum-free culture medium, in order to avoid contamina- 
tion by exogenous proteins during the isolation procedure, and 
then induced with HMBA. At time intervals, the cell-free me- 
dium was collected and analyzed for its content in DEF activ- 
ity. As shown in Fig. 2A, DEF activity was progressively re- 
leased from the cells, reaching a maximum between the third 
and the fourth hour after the addition of HMBA. No apprecia- 
ble amounts of DEF activity was detected in the medium in 
which cells had been incubated in the absence of HMBA. 
In order to identify the nature of this protein factor and 
evaluate the extent of the secretion process, MEL cells, sus- 
pended in serum-free medium, were incubated for 4 h with 
HMBA, then both cells and medium were separately collected, 
submitted to affinity chromatography on heparin-immobilized 
column, and analyzed for their content in the protein express- 
ing DEF activity. As shown in Fig. 2B, a large amount of this 
protein was recovered from the extracellular medium as a single 
peak of DEF  activity. A lower protein peak, eluting at the same 
salt concentration and containing the same activity was recov- 
ered from the cell soluble fraction (Fig. 2C). The amount of 
activity present in the extracellular medium resulted to be ap- 
proximately 1.5-1.6-fold greater than that recovered from the 
cell soluble fraction, indicating that approximately 60-65% of 
the total DEF protein had been released uring cell stimulation. 
The possibility that this high recovery in the extracellular me- 
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Fig. 2. Release of differentiation enhancing activity in the culture medium of stimulated MEL cells. C44 MEL cells (4 × 10 7 cells) were resuspended 
in 1 ml of serum-free culture medium containing 5mM HMBA and incubated at 37°C. (A) At the indicated times, aliquots (0.1 ml) of cell suspension 
were collected, cells were pelletted by centrifugation and 1 ¢tl of cell-free xtracellular medium was used for the assay of DEF activity as described 
in section 2. (B and C) After 4 h of stimulation, cells and extracellular medium were separately collected by centrifugation a d the cell soluble fraction 
prepared as specified under section 2. Both cell soluble fraction (B) and extracellular medium (C) were submitted to chromatography on a 
heparin-immobilized column as described in section 2. Aliquots (1 pl) of the eluted fractions were used for the assay of DEF activity. 
dium could be due to cell death was ruled out on the basis of 
the large difference between the amount of DEF  protein re- 
leased and the extent of cell death, which involved only 6-8% 
of total cells, as measured uring the entire experiment. 
The peak of DEF  protein, obtained from the extracellular 
medium of MEL cells, was further purified, following the pro- 
cedure described in section 2, and finally analyzed using a 
size-exclusion chromatography (Fig. 3). The elution volume of 
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Fig. 3. Determination of the molecular mass of DEF purified from the 
extracellular medium of MEL cells. DEF was purified from the ex- 
tracellular medium of C44 MEL cells, as reported in section 2, and 
loaded onto a TSK gel G-2000 column equilibrated with 50 mM sodium 
phosphate buffer, pH 7.0. Fractions of 0.4 ml were collected and ali- 
quots of 1/11 assayed for DEF activity as described under section 2. The 
arrows indicate the elution volumes of standard proteins having the 
indicated molecular masses. In the inset: SDS-PAGE of the indicated 
fractions was performed, as specified in section 2. The arrow indicates 
the migration of a 29 kDa standard protein. 
the peak indicated that the molecular mass of the protein cor- 
responded to 29 kDa; moreover the protein under this peak, 
submitted to SDS-PAGE, was found to migrate as a single 
band, with a mobility corresponding again to the same molec- 
ular mass (see inset in Fig. 3). 
3.3. Molecular and functional compar&on between DEF protein 
isolated from cell soluble fraction and from extracelIular 
medium 
The two preparations of DEF  protein, respectively isolated 
from the soluble fraction and from the extracellular medium of 
MEL cells, were tested for their efficiency in promoting in- 
crease in the accumulation of benzidine reactive cells, following 
exposure of MEL cells to HMBA.  As shown in Fig. 4, both 
proteins showed identical efficiencies. Moreover, the N-termi- 
nal sequences and the sequences of three tryptic peptides were 
analyzed and resulted to be identical in the two proteins (data 
not shown). It has been reported that HMG1 preparations 
from rat brain contain at least hree homologous polypeptides 
[21]. The absence of an Ala residue at the positions 1 and 14 
and of a Lys residue at the position 9, which have been de- 
scribed to be present in co-purifying proteins [21 ], excluded the 
presence of such HMG1 isoforms in the intracellular as well as 
in the extracellular DEF  protein purified from MEL cells. 
These results demonstrate that following induction with 
HMBA,  DEF  is rapidly released from the intracellular com- 
partment of MEL  cells and progressively accumulated in the 
culture medium, thus suggesting an extracellular localization as 
the site of expression of the DEF  function. 
3.4. Decay of DEF mRNA during cell differentiation 
To gain insight into the function of DEF  and specifically to 
tentatively verify if its stimulatory effect could be related to the 
completion of the entire differentiation process, we have evalu- 
ated the level of DEF  mRNA during the early times of MEL 
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cells differentiation. As shown in Fig. 5, the level of DEF 
mRNA decreases, following the addition of HMBA, and after 
4 h is 3-fold reduced with respect o the original value. This 
result could be preliminarly interpreted as an indication for the 
requirement for DEF limited to the early steps of cell differen- 
tiation. 
4. D iscuss ion 
We have previously reported that MEL cells contain a 29 
kDa protein, which we named DEF, that, upon addition to the 
culture medium, increases 34-fold the rate of chemically in- 
duced differentiation f these cells [7]. Structural studies have 
indicated that the amino acid sequence of this protein is identi- 
cal to that of a mouse HMG1 protein [19], designated as 'am- 
photerin' due to characteristic distribution of charged amino 
acids [10]. A number of biological functions have been sug- 
gested for HMG1 protein, mostly derived from its proposed 
nuclear localization [11]. It has been reported that HMG1 pro- 
tein binds to DNA, thereby modifying, through a calcium de- 
pendent mechanism, its structural organization [22]. However, 
the peculiar highly charged nature of HMG1 protein may also 
suggest an association with other cell components such as the 
internal surface of plasma membranes, an hypothesis that at 
present has not yet been tested. Of particular interest is the 
observation that in N18 neuroblastoma cells the functional 
localization of this protein seems to occur at the level of the 
external surface of plasma membranes or of the extracellular 
matrix, where it is involved in neurite outgrowth [10]. To pro- 
vide an unequivocal identification and characterization of this 
protein factor from MEL cells, in the present study we have 
explored the functional properties of the recombinant protein 
obtained by the expression i  E. coli of the DEF cDNA ob- 
tained from MEL cells. The fusion protein was shown to be 
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Fig. 4. Efficiency of DEF obtained from intracellular and extracellular 
MEL cell sources. DEF was purified from the MEL cell soluble fraction 
of unstimulated cells (e) or from the serum-free medium obtained after 
4 h of MEL cells stimulation with 5 mM HMBA (©), as specified in 
section 2. The indicated amounts of purified protein were used to assay 
DEF activity as reported in section 2. 
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Fig. 5. DEF mRNA in resting and HMBA stimulated MEL cells. C44 
MEL cells (7 x 105 cells/ml) were incubated for 4 h at37°C in complete 
culture medium in the absence or in the presence of 5 mM HMBA. 
Total mRNA was then isolated and submitted to N rthern blot analysis 
as reported in section 2 using 32p-labelled cDNA probes for HMG1 and 
fl-actin. Radioactivity associated with the ,6-actin band was evaluated 
to normalize the amount of mRNA used for both samples. 
equally efficient, as the native protein, in stimulating c~-PKC 
activity (data not shown) and in accelerating the rate of HMBA 
induced MEL cell differentiation. Likewise amphoterin, DEF 
seems to be functionally dependent from an extracellular local- 
ization as suggested by the observation that its activity is ex- 
pressed following addition to the MEL cell culture medium. In 
the present paper, we provide additional evidence to this hy- 
pothesis by the direct demonstration that DEF activity, detect- 
able in the culture medium, following stimulation ofMEL cells 
with HMBA, is the result of a secretory process. In fact, it has 
been found that the extracellular ccumulation f DEF is par- 
alleled by a corresponding decrease in its intracellular level. 
Furthermore, amino acid sequencing of secreted DEF revealed 
a complete identity of this protein with DEF prepared from the 
soluble fraction of MEL cell, and with brain amphoterin [10]. 
In conclusion, the present data not only suggest anovel biolog- 
ical function for HMG1 type proteins but emphasize, with 
respect o MEL cell erythroid differentiation, the significant 
role of a differentiation enhancing factor (DEF) that is ex- 
pressed and retained in the intracellular compartment and is 
rapidly secreted to become active when these cells are stimu- 
lated by the inducer. Further experiments are in progress to 
explore the site of action of DEF in MEL cells with special 
emphasis to PKC activation and decay, as suggested by the well 
documented stimulatory effect of this factor on c~-PKC activity 
[8,9]. 
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